Prof Mark R Hutchinson

Cited by

	All	Since 2018
Citations	13985	7525
h-index	61	47
i10-index	150	134

1500

750

375

1125

2007200820092010201120122013201420152016201720182019202020212022202377 118 196 319 427 612 636 892 949 996 1041 1041 1174 1238 1363 1416 1264

Public access

View all

117 articles

18 articles

available

not available

Based on funding mandates

Co-authors

Steven F. MaierUniversity of Colorado BoulderVerified email at colorado.edu
Andrew SomogyiUniversity of Adelaide, Discipline of PharmacologyVerified email at adelaide.edu.au
Peter M. GraceAssociate Professor, University of Texas MD Anderson Cancer Center, HoustonVerified email at mdanderson.org
Janet CollerSenior Lecturer in Pharmacology, the University of AdelaideVerified email at adelaide.edu.au
Prof Paul RolanUniversity of AdelaideVerified email at adelaide.edu.au
Xiaohui WangPrincipal Investigator (Professor), Chinese Academy of Sciences (CAS)Verified email at ciac.ac.cn
Hang Hubert Yin 清华尹航Professor & Deputy Dean, School of Pharmaceutical Sciences, Tsinghua UniversityVerified email at tsinghua.edu.cn
Ewa GoldysProfessor, Deputy Director, Australian Research Council Centre of Excellence for NanoscaleVerified email at unsw.edu.au
Vasiliki StaikopoulosUniversity of Adelaide; Center for NanoScale BiophotonicsVerified email at adelaide.edu.au
Sarah A. RobertsonRobinson Research Institute & Adelaide Medical School, University of AdelaideVerified email at adelaide.edu.au
Guozhen LiuProfessor of Biomedical Engineering, The Chinese University of Hong Kong, Shenzhen; The UniversityVerified email at cuhk.edu.cn
Sanam MustafaUniversity Research Fellow, University of AdelaideVerified email at adelaide.edu.au
Lachlan MoldenhauerRobinson Research Institute, University of AdelaideVerified email at adelaide.edu.au
Erik P SchartnerInstitute for Photonics and Advanced Sensing, University of AdelaideVerified email at adelaide.edu.au
Jonathan TukeSenior Lecturer, School of Mathematical Sciences, The University of AdelaideVerified email at adelaide.edu.au
Sondra BlandUniversity of Colorado DenverVerified email at ucdenver.edu
Erin D MilliganUniversity of New MexicoVerified email at salud.unm.edu
Heilie KwokFlinders UniversityVerified email at flinders.edu.au
Hongyuan LiChangchun Institute of Applied Chemistry, Chinese Academy of SciencesVerified email at ciac.ac.cn
Femke Buisman-PijlmanAssociate Professor, University of MelbourneVerified email at unimelb.edu.au

Prof Mark R Hutchinson

Director, ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) & ARC Future Fellow, Adelaide

Verified email at adelaide.edu.au - Homepage

Glia Pain Animal Welfare Neuropharmacology Psychoneuroimmunology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Pathological pain and the neuroimmune interface PM Grace, MR Hutchinson, SF Maier, LR Watkins Nature Reviews Immunology 14 (4), 217-231, 2014	870	2014
Evidence that opioids may have toll-like receptor 4 and MD-2 effects MR Hutchinson, Y Zhang, M Shridhar, JH Evans, MM Buchanan, TX Zhao, ... Brain, behavior, and immunity 24 (1), 83-95, 2010	550	2010
Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4) MR Hutchinson, Y Zhang, K Brown, BD Coats, M Shridhar, PW Sholar, ... European Journal of Neuroscience 28 (1), 20-29, 2008	466	2008
Morphine activates neuroinflammation in a manner parallel to endotoxin X Wang, LC Loram, K Ramos, AJ de Jesus, J Thomas, K Cheng, A Reddy, ... Proceedings of the National Academy of Sciences 109 (16), 6325-6330, 2012	459	2012
The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia LR Watkins, MR Hutchinson, KC Rice, SF Maier Trends in pharmacological sciences 30 (11), 581-591, 2009	441	2009
Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids LR Watkins, MR Hutchinson, A Ledeboer, J Wieseler-Frank, ED Milligan, ... Brain, behavior, and immunity 21 (2), 131, 2007	440	2007
Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia MR Hutchinson, Y Shavit, PM Grace, KC Rice, SF Maier, LR Watkins Pharmacological Reviews 63 (3), 772-810, 2011	431	2011
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward MR Hutchinson, ST Bland, KW Johnson, KC Rice, SF Maier, LR Watkins The Scientific World Journal 7, 98-111, 2007	422	2007
Toll‐like receptor 4 in CNS pathologies MM Buchanan, M Hutchinson, LR Watkins, H Yin Journal of neurochemistry 114 (1), 13-27, 2010	389	2010
Glia: novel counter-regulators of opioid analgesia LR Watkins, MR Hutchinson, IN Johnston, SF Maier Trends in neurosciences 28 (12), 661-669, 2005	389	2005
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia MR Hutchinson, BD Coats, SS Lewis, Y Zhang, DB Sprunger, N Rezvani, ... Brain, behavior, and immunity 22 (8), 1178-1189, 2008	367	2008
Toll-like receptors in chronic pain L Nicotra, LC Loram, LR Watkins, MR Hutchinson Experimental neurology 234 (2), 316-329, 2012	309	2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcement MR Hutchinson, AL Northcutt, T Hiranita, X Wang, SS Lewis, J Thomas, ... Journal of Neuroscience 32 (33), 11187-11200, 2012	289	2012
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) MR Hutchinson, SS Lewis, BD Coats, DA Skyba, NY Crysdale, ... Brain, behavior, and immunity 23 (2), 240-250, 2009	268	2009
“Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids LR Watkins, MR Hutchinson, ED Milligan, SF Maier Brain research reviews 56 (1), 148-169, 2007	229	2007
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β SS Lewis, MR Hutchinson, N Rezvani, LC Loram, Y Zhang, SF Maier, ... Neuroscience 165 (2), 569-583, 2010	209	2010
Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression JM Schwarz, MR Hutchinson, SD Bilbo Journal of Neuroscience 31 (49), 17835-17847, 2011	205	2011
Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia MR Hutchinson, AL Northcutt, LW Chao, JJ Kearney, Y Zhang, ... Brain, behavior, and immunity 22 (8), 1248-1256, 2008	205	2008
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling AL Northcutt, MR Hutchinson, X Wang, MV Baratta, T Hiranita, ... Molecular psychiatry 20 (12), 1525-1537, 2015	200	2015
Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence JK Coller, MR Hutchinson Pharmacology & therapeutics 134 (2), 219-245, 2012	192	2012

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors